Analytical and Problem solving, AWS, Azure, Linux Operating system, R Programming, Unix Operating system
Principal Biostatistician
Denali Therapeutics is dedicated to developing breakthrough therapies for neurodegenerative diseases through our deep commitment to degeneration biology and principles of translational medicine.
The Opportunity
Denali Therapeutics is seeking to recruit an experienced Principal Biostatistician. The candidate will lead Biostatistics planning activities and deliverables in support of Denali’s core clinical development programs and help shape strategies for clinical development programs. The ideal candidate will guide analytical aspects of a core program entering late stage development, inform study designs, develop and implement novel statistical and computational techniques for analyzing data generated both in house and by external CROs, lead reporting and analysis deliverables, and use a combination of curiosity and statistical acumen to identify and solve interesting problems. This position will report to the Senior Director of Biometrics.
Responsibilities
Requirements
Denali is committed to its core company value of unity by creating a diverse and inclusive environment. We are proud to be an equal opportunity employer and do not discriminate against any employee or applicant for employment because of race, color, sex, age, national origin, religion, sexual orientation, gender identity and/or expression, status as a veteran, basis of disability, or any other federal, state, or local protected class.
Salary Range: $185,000 to $222,333. Compensation for the role will depend on a number of factors, including a candidate’s qualifications, skills, competencies, and experience. Denali offers a competitive total rewards package, which includes a 401k, healthcare coverage, ESPP and a broad range of other benefits. Learn more at https://www.denalitherapeutics.com/careers
*This compensation and benefits information is based on Denali’s good faith estimate as of the date of publication and may be modified in the future.
Denali Therapeutics is dedicated to defeating neurodegenerative diseases by breaking through historical barriers in scientific research and clinical development in order to deliver safe and effective medicines to patients and families. Our scientific approach is based on three core principles: rigorous assessment of genetic targets, engineering brain delivery, and using biomarkers to guide development.
South San Francisco, CA, USA
4-6 year